文献速递美容整形创面修复

自体脂肪移植联合富血小板血浆面部与手部自身对照初步临床试验

A Preliminary Clinical Trial Comparing Split Treatments to the Face and Hand With Autologous Fat Grafting and Platelet-Rich Plasma (PRP): A 3D, IRB-Approved Study.
PubMed 文献 · Aesthet Surg J · 2019-01-01

本研究经伦理批准,对10例患者面部和手部采用自身对照,比较脂肪联合富血小板血浆(PRP)与脂肪联合生理盐水的安全性和疗效。3D Vectra分析显示脂肪/PRP部位1年平均体积变化百分比高于脂肪/生理盐水部位,但无统计学显著性;两种治疗均无不良事件,仅术后水肿、红斑、瘀斑和压痛持续最多1至2周。作者结论认为需更多患者和更长随访以确定PRP是否增加脂肪移植保留。

要点

  • 脂肪联合PRP与联合生理盐水相比,1年体积保留率更高但无统计学显著性。
  • 两种治疗均安全,无不良事件,术后反应最多持续1至2周。
  • 3D Vectra、VISIA和Cortex分析可评估面部和手部体积恢复。

核心结论

  • 自体脂肪移植仍是面部和手部美容手术安全有效的辅助手段。
  • PRP能否提高脂肪移植保留率尚需更多患者和更长随访确定。

研究设计与样本

  • 经机构审查委员会批准的自身对照初步临床试验,纳入10例患者。
  • 每例患者面部两侧和双手分别接受脂肪联合PRP或脂肪联合生理盐水治疗。

主要发现

  • 3D Vectra分析显示脂肪/PRP部位1年平均体积变化百分比高于脂肪/生理盐水部位,但无统计学显著性。
  • 三名独立评估者可评估两种治疗后面部颧脂肪垫、鼻颊沟、鼻唇沟及手部掌骨间凹陷的体积恢复。
  • 一年研究期间未观察到不良事件,围手术期水肿、红斑、瘀斑和压痛最多持续1至2周。

临床怎么用

  • 脂肪移植可用于面部和手部美容手术,联合PRP的安全性良好。
  • 目前证据尚不足以常规推荐PRP增强脂肪移植保留,需个体化决策。

局限性

  • 样本量小(10例),随访1年,需更多患者和更长随访验证PRP作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Numerous methodologies have been suggested to enhance fat graft survival, but few long-term studies are available. OBJECTIVES: The authors of this institutional review board-approved study investigated the safety and efficacy of utilizing platelet-rich plasma (PRP). METHODS: Each of 10 patients received equal volumes of syringe-harvested, centrifuged fat to opposing midfaces with a lateral submuscular aponeurotic system-plication or no face lift and hands that were combined with equal volumes of either concentrated PRP or normal saline. Comparable assessments of fat retention/baseline values by 3D Vectra Analysis, VISIA, and Cortex facial skin analyses were performed. Clinical results were judged on a visual analogue scale. RESULTS: The average percent change in mean volume assessments at the fat/PRP sites from baseline values, as profiled by 3D Vectra Analysis, demonstrated a higher, but statistically nonsignificant value over 1 year than the percent value changes at the fat/normal saline sites in the opposing face or hand. Three independent evaluators were able to assess volume restorations to the malar fat pad, naso-jugal groove, and nasolabial fold as well as to intermetacarpal hollowness with reduction of visible veins and tendons in the anterior midface and hands with both treatments. No adverse events were observed over the year-long study. Perioperative edema, erythema, bruising, and tenderness lasted up to 1 to 2 weeks at most. CONCLUSIONS: Autologous fat grafting continues to be a safe and effective adjunct in facial and hand aesthetic surgery. This study will require more patients and longer follow-up periods to determine whether PRP has a potential role to increase fat graft retention in aesthetic patients.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Sasaki GH. A Preliminary Clinical Trial Comparing Split Treatments to the Face and Hand With Autologous Fat Grafting and Platelet-Rich Plasma (PRP): A 3D, IRB-Approved Study. Aesthet Surg J. 2019. PMID: 30534955. doi:10.1093/asj/sjy254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。